Scientists find new drug stopping recurring brain tumor growth
When a non-metastatic brain tumor—a meningioma—recurs after surgery and radiation treatment, a patient is out of options.
No drugs are approved for these aggressive tumors,...
Scientists find who will respond best to ketamine for severe depression
In a study from the Baylor College of Medicine, scientists found a way to determine who will respond best to ketamine for severe depression.
While...
COVID-19 virus can stay in brain, elsewhere in body for 8 months
In a study from the National Institutes of Health, scientists analyzed tissue samples from the autopsies of 44 people who died with COVID-19.
They found...
New test could detect Alzheimer’s disease in blood
In a study from the University of Pittsburgh, scientists developed a test to detect a novel marker of Alzheimer's disease neurodegeneration in a blood...
Cannabis strongly linked to death risk in high blood pressure
A recent study from Georgia State University found that marijuana use is linked to a three-fold risk of death from high blood pressure.
They examined...
Scientists develop new COVID pill better than Paxlovid
In a study from Shanghai Jiao Tong University, scientists developed a new medication that COVID patients can take to prevent severe disease.
The treatment is...
Why apples may help reduce high blood pressure
A recent study from Southern Medical University found that intake of the flavonoid quercetin can greatly reduce high blood pressure in people suffering from...
Scientists develop promising drug to treat chronic lung disease
In a study from the National University of Singapore, scientists have discovered a novel property of a protein found in human lungs that could...
Women less likely to go back to work after severe stroke
In a study from Johannes Gutenberg University, scientists found more than one-third of people who have a clot removed from a major blood vessel...
This drug combo may help 1 in 3 patients with deadly brain cancer
A drug combo could lead to FDA approval of the first new drug treatment in more than a decade for glioblastoma, the most common and aggressive type of brain cancer.